Minnesota-based medical device maker NeoChord receives CE Mark approval to market its DS1000 Mitral Valve Repair Device in European Union.
Minnesota device maker NeoChord won CE Mark approval in the European Union for its DS1000 Mitral Valve Repair system, the company announced this week.
The device allows the implantation of artificial chordae tendinae, thread-like tissues that anchor the leaflets of the mitral valve to heart muscle. Surgeons can use the device to repair mitral valve prolapse via a transapical, off-pump procedure, according to the company.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...